'It's more about the heroin': Injection drug users' response to an overdose warning campaign in a Canadian setting

Addiction

Volumn 108, Issue 7, 2013, Pages 1270-1276

  Kerr, Thomas ^a,b   Small, Will ^a,c   Hyshka, Elaine ^a,d   Maher, Lisa ^e   Shannon, Kate ^a,b  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c SIMON FRASER UNIVERSITY   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Heroin; Injection drug use; Overdose; Public health warning

Indexed keywords

DIAMORPHINE; NARCOTIC AGENT;

ADULT; CANADA; DRUG OVERDOSE; DRUG USE; FEMALE; HEROIN DEPENDENCE; HUMAN; MALE; MIDDLE AGED; PSYCHOLOGY; PUBLIC HEALTH SERVICE; QUALITATIVE RESEARCH; RISK FACTOR; SUBSTANCE ABUSE; ARTICLE; PSYCHOLOGICAL ASPECT;

ADULT; BRITISH COLUMBIA; DRUG OVERDOSE; DRUG USERS; FEMALE; HEROIN; HEROIN DEPENDENCE; HUMANS; MALE; MIDDLE AGED; NARCOTICS; PUBLIC HEALTH PRACTICE; QUALITATIVE RESEARCH; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84878942314     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12151     Document Type: Article

References (35)

1. Darke S., Hall W. Heroin overdose: research and evidence-based intervention. J Urban Health 2003; 80: 189-200.
2. Dietze P., Jolley D., Fry C., Bammer G., Moore D. When is a little knowledge dangerous? Circumstances of recent heroin overdose and links to knowledge of overdose risk factors. Drug Alcohol Depend 2006; 84: 223-230.
3. Rhodes T., Mikhailova L., Sarang A., Lowndes C.M., Rylkov A., Khutorskoy M., Renton A. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment. Soc Sci Med 2003; 57: 39-54.
4. Rhodes T., Singer M., Bourgois P., Friedman S. R., Strathdee S. The social structural production of HIV risk among injecting drug users. Soc Sci Med 2005; 61: 1026-1044.
5. Sorensen J. L., London J., Tusel D., Wolfe R., Washburn A. Mass media as drug users' key information source on overdoses. Am J Public Health 1992; 82: 1294-1295.
6. Freeman R. C., French J. F. What is the addicts' grapevine when there's 'bad dope'? An investigation in New Jersey. Public Health Rep 1995; 110: 621-624.
7. Fielden S. J., Marsh D. C. It's time for Canadian community early warning systems for illicit drug overdoses. Harm Reduct J 2007; 4: 10.
8. Miller P. G. Media reports of heroin overdose spates: public health messages, moral panics or risk advertisments? Crit Public Health 2007; 17: 113-121.
9. Wood E., Kerr T. What do you do when you hit rock bottom: responding to drugs in the City of Vancouver. Int J Drug Policy 2006; 17: 55-60.
10. CBC. Killer heroin doubles B.C. overdose fatalities. 2011. Available at: http://www.cbc.ca/news/health/story/2011/05/05/bc-killer-heroin.html (accessed 8 January 2012) (Archived at http://www.webcitation.org/6EvFAbWbl on 6 March 2013).
11. BC Coroners Service. BC Coroners Service warns of rise in heroin-related deaths. 2011. Available at: http://www2.news.gov.bc.ca/news_releases_2009-2013/2011PSSG0059-000493.pdf (accessed 8 January 2012) (Archived at http://www.webcitation.org/6EvF7WwfK on 6 March 2013).
12. Kerr T., Small D., Moore D., Wood E. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility. Int J Drug Policy 2007; 18: 37-45.
13. Rhodes T. The 'risk environment': a framework for understanding and reducing drug-related harm. Int J Drug Policy 2002; 13: 85-94.
14. Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Policy 2009; 20: 193-201.
15. Moore D. Governing street-based injecting drug users: a critique of heroin overdose prevention in Australia. Soc Sci Med 2004; 59: 1547-1557.
16. Fairbairn N., Small W., Van Borek N., Wood E., Kerr T. Social structural factors that shape assisted injecting practices among injection drug users in Vancouver, Canada: a qualitative study. Harm Reduct J 2010; 7: 20.
17. Bourgois P. The moral economies of homeless heroin addicts: confronting ethnography, HIV risk, and everyday violence in San Francisco shooting encampments. Subst Use Misuse 1998; 33: 2323-2351.
18. DeBeck K., Shannon K., Wood E., Li K., Montaner J., Kerr T. Income generating activities of people who inject drugs. Drug Alcohol Depend 2007; 91: 50-56.
19. Dietze P., Fitzgerald J. Interpreting changes in heroin supply in Melbourne: droughts, gluts or cycles? Drug Alcohol Rev 2002; 21: 295-303.
20. Wood E., Stoltz J., Li K., Montaner J. S., Kerr T. Changes in Canadian heroin supply coinciding with the Australian heroin shortage. Addiction 2006; 101: 689-695.
21. Grund J. P., Friedman S. R., Stern L. S., Jose B., Neaigus A., Curtis R. etal. Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens. Soc Sci Med 1996; 42: 691-703.
22. Peretti-Watel P., Moatti J. Understanding risk behaviours: how the sociology of deviance may contribute? The case of drug-taking. Soc Sci Med 2006; 63: 675-679.
23. Fitzgerald J. L. Mapping the experience of drug dealing risk environments: an ethnographic case study. Int J Drug Policy 2009; 20: 261-269.
24. Kerr T., Small W., Johnston C., Li K., Montaner J. S., Wood E. Characteristics of injection drug users who participate in drug dealing: implications for drug policy. J Psychoactive Drugs 2008; 20: 147-152.
25. Dietze P., Jolley D., Fry C. L., Bammer G., Moore D. When is a little knowledge dangerous?: circumstances of recent heroin overdose and links to knowledge of overdose risk factors. Drug Alcohol Depend 2006; 84: 223-230.
26. Darke S., Hall W., Weatherburn D., Lind B. Fluctuations in heroin purity and the incidence of fatal heroin overdose. Drug Alcohol Depend 1999; 54: 155-161.
27. Marshall B. D., Milloy M. J., Wood E., Montaner J. S., Kerr T. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study. Lancet 2011; 377: 1429-1437.
28. Small W., Shoveller J., Moore D., Tyndall M., Wood E., Kerr T. Injection drug users' access to a supervised injection facility in Vancouver, Canada: the influence of operating policies and local drug culture. Qual Health Res 2011; 21: 743-756.
29. Maher L., Salmon A. Supervised injecting facilities: how much evidence is enough? Drug Alcohol Rev 2007; 26: 351-353.
30. Debeck K., Wood E., Qi J., Fu E., McArthur D., Montaner J. etal. Interest in low-threshold employment among people who inject illicit drugs: implications for street disorder. Int J Drug Policy 2011; 22: 376-384.
31. Richardson L., Sherman S. G., Kerr T. Employment amongst people who use drugs: a new arena for research and intervention? Int J Drug Policy 2012; 23: 3-5.
32. Piper T. M., Stancliff S., Rudenstine S., Sherman S., Nandi V., Clear A. etal. Evaluation of a naloxone distribution and administration program in New York City. Subst Use Misuse 2008; 43: 858-870.
33. Sporer K. A., Kral A. H. Prescription naloxone: a novel approach to heroin overdose prevention. Ann Emerg Med 2007; 49: 172-177.
34. Wood E., Werb D., Kazatchkine M., Kerr T., Hankins C., Gorna R. etal. Vienna Declaration: a call for evidence-based drug policies. Lancet 2010; 376: 310-312.
35. Griffiths P., Mounteney J., Lopez D., Zobel F., Gotz W. Monitoring the European drug situation: the ongoing challenge for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Addiction 2012; 107: 254-258.